Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Randomized Controlled Trial

Clinical Trial

Research Support, N.I.H., Extramural

Comparative Study

Publication Year

From

Quick links

Individual year

2025

2024

2023

2022

2021

2018

2017

2016

2015

2014

2013

2011

2010

2009

2007

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Organic Cation Transporter 2""[mesh_terms]

21 Results

Searching titles within these results

Regulation of Transporters for Organic Cations by High Glucose.

Martin Steinbüchel, Johannes Menne, Rita Schröter, Ute Neugebauer, Eberhard Schlatter, Giuliano Ciarimboli

International journal of molecular sciences 2023;24(18):14051

Free Full Text

Abstract

The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).

Morena L Sutter, Lara Console, Anne-Fleur Fahner, Sophia L Samodelov, Zhibo Gai, Giuliano Ciarimboli, Cesare Indiveri, Gerd A Kullak-Ublick, Michele Visentin

Biochemical pharmacology 2022;194():114840

Free Full Text

Abstract

Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.

Claudia Neul, Ute Hofmann, Elke Schaeffeler, Stefan Winter, Kathrin Klein, Kathleen M Giacomini, Michel Eichelbaum, Matthias Schwab, Anne T Nies

British journal of pharmacology 2021;178(6):1459-1474

Free Full Text

Abstract

The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?

Xiaoyan Chu, Kelly Bleasby, Grace Hoyee Chan, Irene Nunes, Raymond Evers

Drug metabolism and disposition: the biological fate of chemicals 2018;44(9):1498-509

Full Text

Abstract

Influence of OCT2 gene variants on metformin efficacy in type 2 diabetes: insights into pharmacogenomics and drug interactions.

Mohanad Odeh, Iman Aolymat, Ali Mussa, Omar Abuyaman, Ma'mon M Hatmal, Amin N Olaimat, Mohammad A I Al-Hatamleh, Heba Tayyem, Aymen Abuawad, Rana Qawaqzeh

Journal of translational medicine 2025;23(1):884

Free Full Text

Abstract

Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins.

Renke Maas, Jörg König, Martin F Fromm, Lorenz A Scherpinski

Amino acids 2025;57(1):34

Free Full Text

Abstract

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N-(7-[F]fluoro-9H-fluoren-2-yl)asparaginate, [F]RP-115.

Chih-Kai Chao, David M Wilson, Henry F VanBrocklin, Joseph Blecha, Youngho Seo, Ilona Polvoy, Ryan Michael Nillo, John R Forsayeth, John M Gerdes

Nuclear medicine and biology 2025;142-143():108992

Free Full Text

Abstract

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

Ying Chen, Shuanglian Li, Chaline Brown, Stephen Cheatham, Richard A Castro, Maya K Leabman, Thomas J Urban, Ligong Chen, Sook Wah Yee, Ji Ha Choi, Yong Huang, Claire M Brett, Esteban G Burchard, Kathleen M Giacomini

Pharmacogenetics and genomics 2009;19(7):497-504

Free Full Text

Abstract

Comparative analysis of the physiological and transport functions of various sources of renal proximal tubule cells under static and fluidic conditions in PhysioMimix T12 platform.

Courtney Sakolish, Ivan Rusyn, Allison N Dickey, Stephen S Ferguson, Haley L Moyer, Han-Hsuan D Tsai, Lucie C Ford, Piyush Bajaj, Remi Villenave, Philip Hewitt, Jason Stanko

Drug metabolism and disposition: the biological fate of chemicals 2025;53(1):100001

Full Text

Abstract

Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Erik Rytting, Jordan Bryan, Marylee Southard, Kenneth L Audus

Biochemical pharmacology 2007;73(6):891-900

Free Full Text

Abstract

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).

Joachim Strobel, Fabian Müller, Oliver Zolk, Beate Endreß, Jörg König, Martin F Fromm, Renke Maas

Amino acids 2014;45(4):989-1002

Full Text

Abstract

Organic Cation Transporter-Mediated Clearance of Cardiovascular Drugs: A Pharmacological Perspective.

Omar T Hassan, Reem T Hassan, Rohit R Arora

American journal of therapeutics 2017;23(3):e855-61

Full Text

Abstract

New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans.

Fabian Müller, Arne Gessner, Pia Wenisch, Peter Stopfer, Markus R Heinrich, Jörg König, Martin F Fromm

Clinical pharmacology and therapeutics 2024;117(1):130-142

Free Full Text

Abstract

Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.

Ana Carolina Conchon Costa, Priscila Akemi Yamamoto, Gabriela Rocha Lauretti, Jhohann Richard de Lima Benzi, Cleslei Fernando Zanelli, Vivien Barz, Giuliano Ciarimboli, Natália Valadares de Moraes

Journal of clinical pharmacology 2021;60(8):1076-1086

Full Text

Abstract

The SLC22 family with transporters of organic cations, anions and zwitterions.

Hermann Koepsell

Molecular aspects of medicine 2013;34(2-3):413-35

Full Text

Abstract

Results: 1 – 15 / 21

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Organic Cation Transporter 2""[mesh_terms]

Regulation of Transporters for Organic Cations by High Glucose.

The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).

Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.

The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?

Influence of OCT2 gene variants on metformin efficacy in type 2 diabetes: insights into pharmacogenomics and drug interactions.

Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins.

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N-(7-[F]fluoro-9H-fluoren-2-yl)asparaginate, [F]RP-115.

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

Comparative analysis of the physiological and transport functions of various sources of renal proximal tubule cells under static and fluidic conditions in PhysioMimix T12 platform.

Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).

Organic Cation Transporter-Mediated Clearance of Cardiovascular Drugs: A Pharmacological Perspective.

New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans.

Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.

The SLC22 family with transporters of organic cations, anions and zwitterions.

Results for
""Organic Cation Transporter 2""[mesh_terms]